Unleashing a safe and potent pro-senescence anti-tumor strategy

Shasha Chen1, Beicheng Sun2, Zhongjun Dong3

  • 1Department of Allergy, the First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei 230032, China; Innovative Institute of Tumor Immunity and Medicine (ITIM), Hefei 230032, China; Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei 230032, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China.

Cancer Cell
|March 1, 2024
PubMed